Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 3
2013 2
2015 4
2016 2
2017 3
2018 4
2019 8
2020 10
2021 13
2022 12
2023 5
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study.
Barbanti P, Aurilia C, Egeo G, Proietti S, D'Onofrio F, Torelli P, Aguggia M, Bertuzzo D, Finocchi C, Trimboli M, Cevoli S, Fiorentini G, Orlando B, Zucco M, Di Clemente L, Cetta I, Colombo B, di Poggio MLB, Favoni V, Grazzi L, Salerno A, Carnevale A, Robotti M, Frediani F, Altamura C, Filippi M, Vernieri F, Bonassi S; ERT; for the Italian Migraine Registry study group. Barbanti P, et al. Among authors: favoni v. J Neurol. 2024 May;271(5):2434-2443. doi: 10.1007/s00415-023-12103-4. Epub 2024 Jan 17. J Neurol. 2024. PMID: 38231271 Free PMC article.
Energy Metabolism Impairment in Migraine.
Cevoli S, Favoni V, Cortelli P. Cevoli S, et al. Among authors: favoni v. Curr Med Chem. 2019;26(34):6253-6260. doi: 10.2174/0929867325666180622154411. Curr Med Chem. 2019. PMID: 29932030 Review.
Migraine and cardiovascular diseases.
Pierangeli G, Giannini G, Favoni V, Sambati L, Cevoli S, Cortelli P. Pierangeli G, et al. Among authors: favoni v. Neurol Sci. 2012 May;33 Suppl 1:S47-50. doi: 10.1007/s10072-012-1040-y. Neurol Sci. 2012. PMID: 22644170 Review.
Migraine and sleep disorders.
Cevoli S, Giannini G, Favoni V, Pierangeli G, Cortelli P. Cevoli S, et al. Among authors: favoni v. Neurol Sci. 2012 May;33 Suppl 1:S43-6. doi: 10.1007/s10072-012-1030-0. Neurol Sci. 2012. PMID: 22644169 Review.
Nociception and autonomic nervous system.
Cortelli P, Giannini G, Favoni V, Cevoli S, Pierangeli G. Cortelli P, et al. Among authors: favoni v. Neurol Sci. 2013 May;34 Suppl 1:S41-6. doi: 10.1007/s10072-013-1391-z. Neurol Sci. 2013. PMID: 23695044 Review.
CGRP and migraine from a cardiovascular point of view: what do we expect from blocking CGRP?
Favoni V, Giani L, Al-Hassany L, Asioli GM, Butera C, de Boer I, Guglielmetti M, Koniari C, Mavridis T, Vaikjärv M, Verhagen I, Verzina A, Zick B, Martelletti P, Sacco S; European Headache Federation School of Advanced Studies (EHF-SAS). Favoni V, et al. J Headache Pain. 2019 Mar 12;20(1):27. doi: 10.1186/s10194-019-0979-y. J Headache Pain. 2019. PMID: 30866804 Free PMC article. Review.
Maintenance of response and predictive factors of 1-year GalcanezumAb treatment in real-life migraine patients in Italy: The multicenter prospective cohort GARLIT study.
Vernieri F, Brunelli N, Marcosano M, Aurilia C, Egeo G, Lovati C, Favoni V, Perrotta A, Maestrini I, Rao R, d'Onofrio L, Finocchi C, Aguggia M, Bono F, Ranieri A, Albanese M, Di Piero V, Cevoli S, Altamura C, Barbanti P; GARLIT Study Group. Vernieri F, et al. Among authors: favoni v. Eur J Neurol. 2023 Jan;30(1):224-234. doi: 10.1111/ene.15563. Epub 2022 Sep 26. Eur J Neurol. 2023. PMID: 36097739 Free PMC article.
63 results